VYCOR MEDICAL, INC.

VYCO
Delayed Quote. Delayed  - 07/01 03:16:48 pm
0.141USD +1.44%

VYCOR MEDICAL INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

06/30/2020 | 05:08 pm

Item 7.01 Regulation FD Disclosure



On June 30, 2020, Vycor Medical, Inc. (the "Company") published a press release
entitled "Vycor Medical, Inc. Agrees New NovaVision Licensing Agreement"
announcing a new licensing arrangement with respect to Germany, Austria and
Switzerland with HelferApp GmbH.



The information in Item 7.01 of this report, including Exhibit 99.1, is being
furnished pursuant to Item 7.01 of Form 8-K and shall be deemed "furnished" and
not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liabilities of that section, nor shall
such information be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as
amended.



Item 9.01 Financial Statements and Exhibits







(d) Exhibits:



Exhibit No. Description
99.1 Vycor Medical, Inc. Press Release dated June 30, 2020

© Edgar Online, source Glimpses

Acquiremedia 2020
Copier lien
Latest news on VYCOR MEDICAL, INC.
2d ago
2d ago
05/12
03/27
03/27